Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bringing Treatment Home: Daratumumab Administration by Danish Community Nurses in Multiple Myeloma-A Mixed-Method Study.

Created on 03 Nov 2026

Authors

Kirkegaard Jannie, Rosenberg Tine, Dieperink Karin Brochstedt, Lund Thomas

Published in

Home healthcare now. Volume 44. Issue 6. Pages 355-366. Epub Nov 02, 2026.

Abstract

The expansion of home-based cancer care aims to reduce hospital burden while supporting patient-centered treatment. For patients with multiple myeloma who require long-term therapy and frequent hospital visits, community-based treatment may improve flexibility and quality of life. This prospective mixed-methods study explored the feasibility of community nurses administering subcutaneous daratumumab in patients' homes or local healthcare clinics. Nineteen patients, nine community nurses, and four hospital healthcare professionals participated in interviews or focus groups. Patient-reported quality of life was assessed using the EORTC QLQ-C30. Most patients preferred home- or local-based administration, citing greater comfort, reduced travel, and a greater sense of normalcy. Community nurses and hospital professionals considered the model feasible and safe when supported by structured training, clear guidelines, and effective communication. However, medication delivery and care coordination created logistical challenges that reduced flexibility for some patients. Quality-of-life scores showed no consistent differences between home- and hospital-based treatment. Home administration should consider clinical stability, cognitive function, patient preferences, and daily routines. Successful implementation requires standardized training, clear roles, reliable communication, and efficient workflows. Home-based daratumumab should be offered as an individualized option within integrated cancer care rather than as a universal replacement for hospital-based treatment.

PMID:
42970525
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement